To use this site, please disable the ad blocking feature and reload the page.
This website uses cookies to collect information about your visit for purposes such as showing you personalized ads and content, and analyzing our website traffic. By clicking “Accept all,” you will allow the use of these cookies.
Users accessing this site from EEA countries and UK are unable to view this site without your consent. We apologize for any inconvenience caused.
Yomiuri Shimbun file photo Resigning Kobayashi Pharmaceutical Co. President Akihiro Kobayashi, second from left, speaks at a press conference in March.
The Yomiuri Shimbun
14:02 JST, July 23, 2024
Kobayashi Pharmaceutical Co.’s Senior Executive Director Satoshi Yamane has been promoted to the post of company president after its chairman and president resigned to take responsibility for health problems caused by the company’s supplements containing “benikoji” red rice mold.
The appointment of Yamane, 64, and the resignations of Chairman Kazumasa Kobayashi, 84, and President Akihiro Kobayashi, 53, were approved at a special meeting of the board of directors on Tuesday morning.
After stepping down as chairman, Kazumasa will become a special adviser. After leaving his post as a director without representative rights, Akihiro will concentrate on dealing with a series of problems and establishing compensation for those harmed by the supplement.
Until now, Kobayashi Pharmaceutical has always been headed by a member of the company’s founding family, so Yamane will be the first non-founder to serve as president of the company.
